Filter by: patients
Home > Community Treatment Reports and Side Effects > Nattokinase Treatment Report
What is Nattokinase?

Nattokinase is a dietary supplement extracted from the Japanese foodstuff "Natto", a savoury flavouring made from soybeans. Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Fibrin reducer 2 0
Venous Insufficiency 1 0
General health 1 0
Support circulatory health 1 0
Other 1 0
Circulation problems 1 0

See all 7 patients currently taking Nattokinase

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 2

Reported Dosages

  50 mg weekly 90 mcg daily 100 mg daily 300 mg daily 12,000 other daily
  1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Nattokinase (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 2   Other: 50%
Expense 1   Expense: 25%
Doctor's advice 1   Doctor's advice: 25%
Not indicated 1   Not indicated: 25%

See all 4 patients who’ve stopped taking Nattokinase

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Nattokinase

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Nattokinase

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Nattokinase

Always
 2 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Nattokinase

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 2 100%

Cost

Paid out of pocket

Cost of Nattokinase

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 2 100%
< $25
 0 0%

Report created on February 09, 2012.